Senate Session
The U.S. Senate reconvened and after a brief period of Morning Business speeches returned to debate on Food and Drug Administration Moderniz… read more
The U.S. Senate reconvened and after a brief period of Morning Business speeches returned to debate on Food and Drug Administration Modernization Act. The Act under the title S.830 moved to amend the Federal Food, Drug, and Cosmetic Act and the Public Health Service Act to improve the regulation of food, drugs, devices, and biological products. Members debated and voted on a number of amendments to the bill but did not vote on a final version during this session. The Senate then stood in recess for a brief period while members greeted visiting lawmakers from the European Union. close
Related Video
-
Senate Session
The U.S. Senate considered S. 830, an FDA reform bill that examines how new drugs and medical devices are approved.
-
Senate Session
On this day, the Senate once again took up consideration of the FDA Reform Bill. Debate also continued on the $269 billi…
-
Senate Session
The U.S. Senate began this session with a discussion on a motion to invoke Cloture to the Motion to proceed to the consi…
-
Senate Session
The Senate confirmed Alexis Herman’s nomination for secretary of labor. Members also debated disaster relief and funding…